IRIS
FERRAROTTI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.176
EU - Europa 703
AS - Asia 479
AF - Africa 2
SA - Sud America 2
Totale 2.362
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.170
CN - Cina 460
IE - Irlanda 263
UA - Ucraina 96
FI - Finlandia 84
DE - Germania 78
IT - Italia 55
SE - Svezia 47
GB - Regno Unito 39
BE - Belgio 12
FR - Francia 11
SG - Singapore 11
CA - Canada 6
CZ - Repubblica Ceca 4
DK - Danimarca 4
HK - Hong Kong 4
RU - Federazione Russa 4
NL - Olanda 3
CH - Svizzera 2
MU - Mauritius 2
AR - Argentina 1
AZ - Azerbaigian 1
BR - Brasile 1
ES - Italia 1
IR - Iran 1
JP - Giappone 1
TH - Thailandia 1
Totale 2.362
Salva come PNG Salva come JPEG
Città #
Dublin 263
Chandler 248
Nanjing 106
Jacksonville 99
Ashburn 85
Boardman 85
Ann Arbor 78
Beijing 70
Helsinki 48
Lawrence 46
Princeton 46
Medford 44
Nanchang 42
Dearborn 40
Wilmington 34
Shenyang 31
Shanghai 30
Changsha 29
New York 29
Houston 24
Jiaxing 23
Hebei 22
Vinnytsia 17
Tianjin 15
Hangzhou 14
Piemonte 14
Woodbridge 14
Brussels 12
Redwood City 10
Washington 10
Kunming 9
Pavia 9
Dallas 8
Norwalk 8
Chicago 6
Fairfield 6
Hefei 6
Jinan 6
Singapore 6
Des Moines 5
Brno 4
Canyon Country 4
Hårlev 4
Los Angeles 4
Padova 4
Seattle 4
Toronto 4
Frankfurt am Main 3
Milan 3
Munich 3
Taizhou 3
Tappahannock 3
Zhengzhou 3
Amsterdam 2
Basel 2
Berlin 2
Changchun 2
Chengdu 2
Cornigliano 2
Fort Worth 2
Guidonia 2
Ningbo 2
Orange 2
Phoenix 2
Piscataway 2
Rome 2
San Jose 2
Turin 2
Abbiategrasso 1
Anqing 1
Auburn Hills 1
Bangkok 1
Borås 1
Brockton 1
Chongqing 1
Edmond 1
Esslingen am Neckar 1
Florence 1
Fuzhou 1
Gallarate 1
Guangzhou 1
Haikou 1
Lanzhou 1
Linyi 1
Madrid 1
Monmouth Junction 1
Montreal 1
Nanning 1
Novara 1
Perugia 1
Putian 1
Radeberg 1
Rockville 1
Sacile 1
San Francisco 1
Sanhe 1
Shanwei 1
Shaoxing 1
Sheerness 1
Stockholm 1
Totale 1.805
Salva come PNG Salva come JPEG
Nome #
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 120
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 77
Lyosecretome for use in the treatment of autoimmune diseases 77
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 74
α₁-Antitrypsin level and pheno/genotypes 72
Identification and characterisation of eight novel SERPINA1 null mutations. 72
Expression of receptor for advanced glycation end products in sarcoid granulomas. 68
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 68
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 66
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 63
A regulatory SNP in the Promoter Region of the RAGE Gene 61
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 60
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 59
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 58
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 56
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 55
COPD: no gene left unturned 55
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 55
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 53
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 53
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 52
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 52
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 51
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 51
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 50
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency 50
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 49
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 49
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 46
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 46
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 45
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. 45
Update on α1-antitrypsin deficiency 40
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 38
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization. 37
Alpha-1 antitrypsin deficiency: From the lung to the heart? 37
Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: Enough is enough 34
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 31
α1-Antitrypsin deficiency. 29
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 29
Immune Activation in alpha(1)-Antitrypsin-Deficiency Emphysema Beyond the Protease-Antiprotease Paradigm 27
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 26
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. 23
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. 22
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. 20
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency 20
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 19
Practical dietary advices for subjects with alpha-1 antitrypsin deficiency 14
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review 11
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency 11
null 10
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 9
Recommendations for the measurement of the most important plasma proteins 5
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 5
Long-term effect of α1-antitrypsin augmentation therapy on the decline of fev1 in deficient patients: An analysis of the air database 4
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 4
Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants 3
Protocol for the earco registry: A pan-european observational study in patients with α1-antitrypsin deficiency 3
What is the knowledge on alpha-1 antitrypsin deficiency among Italian pulmonologists? 3
Place of genotyping and phenotype in addition to the assay of serum α -1 antitrypsin 2
Alpha-1 antitrypsin screening in a selected cohort of patients affected by chronic pulmonary diseases in Naples, Italy 2
The importance of n186 in the alpha-1-antitrypsin shutter region is revealed by the novel bologna deficiency variant 2
Clinical manifestations in patients with PI*MMMalton genotypes. A matter still unsolved in alpha-1 antitrypsin deficiency 2
New patient-centric approaches to the management of alpha-1 antitrypsin deficiency 2
Totale 2.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.837
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020453 0 220 19 25 12 40 13 36 16 37 31 4
2020/2021266 24 16 12 17 9 28 14 47 13 33 29 24
2021/2022200 6 2 4 5 1 2 5 16 13 4 28 114
2022/2023726 87 51 6 44 83 68 3 31 315 7 21 10
2023/2024399 26 77 16 10 36 98 11 21 2 53 27 22
2024/202589 20 69 0 0 0 0 0 0 0 0 0 0
Totale 2.432